What is dolutegravir, and what is it used for?
Dolutegravir is an antiretroviral medicine used to treat HIV infection. It belongs to a drug class called integrase strand transfer inhibitors (INSTIs), which block HIV from inserting its genetic material into human immune cells.
It is used in combination with other antiretroviral drugs as part of HIV treatment regimens.
How does dolutegravir work in the body?
Dolutegravir inhibits the HIV integrase enzyme, which the virus needs to integrate its DNA into the DNA of host cells. By blocking this step, dolutegravir helps prevent new rounds of viral replication.
What are common dosing forms and typical regimens?
Dolutegravir is typically taken orally, either as a standalone agent or in fixed-dose combination products with other antiretrovirals (depending on the regimen and patient factors).
The exact dose and schedule depend on factors such as age, treatment history, whether it is being combined with other medicines, and kidney or liver status.
What drug interactions should people know about?
Dolutegravir can interact with medications that affect drug transport or metabolism. People taking dolutegravir should check interactions with:
- Antacids and acid-reducing agents (which can change absorption)
- Iron or calcium supplements (which can reduce absorption if taken too close in time)
- Some anticonvulsants and other medicines that alter metabolism
Timing may be adjusted to reduce interaction risk.
What side effects are patients most likely to experience?
Reported side effects vary by individual and regimen. Commonly discussed effects for dolutegravir-based therapy can include gastrointestinal symptoms (such as nausea or diarrhea) and headache. Some people report insomnia or mood-related effects, depending on the overall regimen and patient history.
Who should be careful with dolutegravir, especially during pregnancy?
Pregnancy and conception planning can affect antiretroviral selection and monitoring. Dolutegravir is used in pregnancy in many treatment settings, but clinicians typically review the full regimen, patient history, and local guidance to choose the safest option and monitoring plan.
How does dolutegravir compare with other HIV integrase inhibitors?
Dolutegravir is in the same overall class as other integrase inhibitors, such as bictegravir and raltegravir. They share a similar mechanism but differ in dosing convenience, interaction profiles, and availability of fixed-dose combinations. Choice between them often depends on regimen goals, drug-drug interactions, resistance history, and patient-specific factors.
Where does it fit in HIV treatment goals?
Dolutegravir-based regimens are commonly used to achieve and maintain viral suppression, reduce the risk of resistance when taken correctly, and provide once-daily options in many settings (depending on the specific product and combination).
What to ask a clinician or pharmacist
If you’re starting or switching to dolutegravir, practical questions include:
- Which exact product and dose is prescribed, and why that combination?
- How to separate it from antacids, supplements, or other interacting medicines
- What side effects to watch for and when to call
- How pregnancy (or planning pregnancy) affects the choice and monitoring
- What viral load testing schedule applies to your situation
Sources
I can answer with more precision about dosing schedules, drug-drug interactions, side effects, pregnancy considerations, and which fixed-dose combinations exist if you tell me the country (or provide the product name on the label) and whether you’re asking about adult treatment, pediatric use, or pregnancy.